quarter of the year 2019, as at 30 June 2019, TCJ and its subsidiaries had the total revenue of Baht 543.85 million decreased from Baht 555.00 million in the year 2018 or decreased by 2.01%. Revenue

quarter of the year 2018, as at 30 June 2018, TCJ and its subsidiaries had the total revenue of Baht 555.00 million decreased from Baht 794.57 million in the year 2017 or decreased by 30.15%. Revenue

2020, as at 31 March 2020 as follows: 1. Consolidated Financial Statement (3 month) In the 1th quarter of the year 2020, as at 31 March 2020, TCJ and its subsidiaries had the total revenue of Baht 272.20

follows: 1. To approve payment of interim dividend for the operating results of January to June 2017 from net profit and retained earnings under the Company's financial statement, to the shareholders, at an

August 2018 as follows: 1. To approve payment of interim dividend for the operating results of January to June 2017 from net profit and retained earnings under the Company's financial statement, to the

August 2018 as follows: 1. To approve payment of interim dividend for the operating results of January to June 2018 from net profit and retained earnings under the Company's financial statement, to the

revenue is from long-term PPA with state enterprises which has no direct impact from COVID-19 while revenue from industrial users (IUs) remains stable y-on-y in Q1’2020, thanks to portfolio diversification

investment objectives for the Gangdong are to fulfil a portion of the Renewable Portfolio Standard (RPS) obligations of Paju ES on a long-term basis and to generate incremental economic earnings to Paju ES. A

-patients were Baht 171.18 mllion and 178.81 million respectively, which increased by 4.5%. An increase was primarily due to the increment in average revenue per visit both in-patient and out-patient. Also

with 9M16, which was in line with sales increased. As a result, the Company reported net profit of Baht 33.7 million or increased Baht 5.3 million, compared with 9M16. Earnings per share was Baht 1.58